# Clinical study of the relationship between hepatitis B core antibody and mechanical ventilation in patients with Guillain-Barré syndrome

**Authors:** Wei Zhang, Qian Yao, Yuqiao Wang, Junxiong Yin, Xinxin Yang

PMC · DOI: 10.3389/fneur.2025.1530286 · Frontiers in Neurology · 2025-02-24

## TL;DR

This study found that patients with Guillain-Barré syndrome who tested positive for hepatitis B core antibody were more likely to need mechanical ventilation.

## Contribution

The study identifies HBcAb positivity as a novel risk factor for mechanical ventilation in Guillain-Barré syndrome patients.

## Key findings

- HBcAb positivity was a significant risk factor for mechanical ventilation in GBS patients.
- Lower MRC scores, bulbar paralysis, autonomic dysfunction, and higher NLR were also associated with the need for MV.
- The study analyzed 159 GBS patients over an 8.5-year period.

## Abstract

The aim of this study was to investigate the association between hepatitis B core antibody (HBcAb) positivity and the need of mechanical ventilation (MV) in patients with Guillain-Barré syndrome (GBS).

We retrospectively analyzed the clinical data of 159 patients who were diagnosed with GBS between December 2014 and April 2023 in the Affiliated Hospital of Xuzhou Medical University. Patients were categorized into two groups according to the need for MV. Variables that were significantly different between the two groups in univariate analysis were analyzed through multivariate logistic regression models.

The final study population included 159 patients, 28 (17.6%) of whom need MV. In univariate analysis, Medical Research council sum score (MRC) on admission (p < 0.001), bulbar paralysis (p < 0.001), autonomic dysfunction (p < 0.001), HBcAb (p = 0.009), neutrophil/lymphocyte ratio (NLR) (p < 0.001), and Serum albumin (p = 0.016) were associated with MV. Multivariate logistic regression analysis showed lower MRC on admission (OR = 0.946, 95%CI: 0.908–0.985, p = 0.008), bulbar paralysis (OR = 3.726, 95%CI: 1.118–12.421, p = 0.032), autonomic dysfunction (OR = 3.804, 95%CI: 1.058–13.679, p = 0.041), HBcAb positivity (OR = 6.154, 95%CI: 1.253–30.229, p = 0.025), and higher NLR (OR = 1.214, 95%CI: 1.039–1.417, p = 0.014) were the risk factors for the need of MV in patients with GBS.

HBcAb positivity increased the risk of MV in patients with GBS. Lower MRC on admission, bulbar paralysis, autonomic dysfunction, and higher NLR were the risk factors for the need for MV.

## Linked entities

- **Diseases:** Guillain-Barré syndrome (MONDO:0016218), hepatitis B (MONDO:0005344)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** GBS (MESH:D020275), hepatitis B (MESH:D006509), bulbar paralysis (MESH:D010244), autonomic dysfunction (MESH:D001342)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11891066/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11891066/full.md

## References

40 references — full list in the complete paper: https://tomesphere.com/paper/PMC11891066/full.md

---
Source: https://tomesphere.com/paper/PMC11891066